Search Results - "Lotun, K"

Interventional Cardiologist Approach to Cardiac Arrest by Lotun, K, Kern, K B

Get full text

Coronary angiographic findings for out-of-hospital cardiac arrest survivors presenting with nonshockable rhythms and no ST elevation post resuscitation by Harhash, AA, Kluge, MA, Muthukrishnan, A., Noc, M., Radsel, P., Jentzer, JC, Seder, DB, Lee, K., Lotun, K., Stub, D., Hsu, C-H., Kern, KB

“…[Display omitted] Recent guidelines suggest that coronary angiography (CAG) should be considered for out-of-hospital cardiac arrest (OHCA) survivors, including…”
Get full text

Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial by Jukema, J Wouter, Szarek, Michael, Zijlstra, Laurien E, de Silva, H Asita, Bhatt, Deepak L, Bittner, Vera A, Diaz, Rafael, Edelberg, Jay M, Goodman, Shaun G, Hanotin, Corinne, Harrington, Robert A, Karpov, Yuri, Moryusef, Angèle, Pordy, Robert, Prieto, Juan C, Roe, Matthew T, White, Harvey D, Zeiher, Andreas M, Schwartz, Gregory G, Steg, P Gabriel

“…Patients with acute coronary syndrome (ACS) and concomitant noncoronary atherosclerosis have a high risk of major adverse cardiovascular events (MACEs) and…”
Get full text

Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial by Szarek, Michael, White, Harvey D, Schwartz, Gregory G, Alings, Marco, Bhatt, Deepak L, Bittner, Vera A, Chiang, Chern-En, Diaz, Rafael, Edelberg, Jay M, Goodman, Shaun G, Hanotin, Corinne, Harrington, Robert A, Jukema, J Wouter, Kimura, Takeshi, Kiss, Robert Gabor, Lecorps, Guillaume, Mahaffey, Kenneth W, Moryusef, Angèle, Pordy, Robert, Roe, Matthew T, Tricoci, Pierluigi, Xavier, Denis, Zeiher, Andreas M, Steg, Ph Gabriel

“…The ODYSSEY OUTCOMES (Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab) trial compared alirocumab with…”
Get full text

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial by Harrington, Robert A, Pordy, Robert, Bhatt, Deepak L., Moryusef, Angèle, Sinnaeve, Peter, Pećin, Ivan, Novaretto, Leonardo P., Codutti, Oscar R., Vico, Marisa L., Bustamante Labarta, Miguel H, Arstall, Margaret A, Garrahy, Paul J, Wollaert, Bart, Kulić, Mehmed, Eliaschewitz, Freddy G, Kaiser, Sergio, Manenti, Euler Roberto Fernandes, Vuurmans, Tycho, Lai, Christopher, Olivares, Claudia, Chen, Jiyan, Huang, Weijian, Li, Xiang, Cheng, Xiaoshu, Wei, Meng, Fan, Zhongcai, Accini Mendoza, Jose L, Ghlonti, Ramaz, Schmidt, Ekkehard, Patsilinakos, Sotiris, Fausto Ovando, Sergio R, Yan, Bryan PY, Merkely, Bela, Premchand, Rajendra K, Kerkar, Prafulla, Patil, Sachin N, Chopda, Manoj, Chopra, Vijay K, Kumar, Vinay, Marco, Valgimigli, Cuccia, Claudio, Ferratini, Maurizio, Doi, Yasuji, Uematsu, Masaaki, Kim, Chongjin, Liew, Houng B, Llamas Esperón, Guillermo Antonio, Suarez Otero, Rodrigo, Kaplan, Refik, Gosselink, Antonius TM, Castillo Leon, Reynaldo P, Hernandez Zuniga, Jose D, Camacho Cosavalente, Luis A, Rodriguez Chavez, Víctor E, Wlodarczak, Adrian, Jaworska, Krystyna, Kubica, Jacek, Tesloianu, Dan N, Constantinescu, Mircea CA, Vishnevsky, Alexander Y, Povzun, Anton, Kanorsky, Sergey, Reuter, Helmuth, Cruz Fernández, Jose M, Worner Diz, Fernando, Bruguera Cortada, Jordi, Valdivielso, Pedro, Ponnamperuma, Chandrike, Huang, Tsuei-Yuan, Sukonthasarn, Apichard, Sansanayudh, Nakarin, Kehasukcharoen, Wirash, Ural, Ertan, Karpenko, Oleksandr, Mostovoy, Yuriy, Malynovsky, Yaroslav, Kopytsya, Mykola, Yagensky, Andriy, Griffiths, Huw, Kurian, John, Palmer, Bruce, White, Lindsey, Klancke, Kim, Waider, Winfried, Henderson, David, Mody, Freny, Park, Hyeun (Tom), Vidovich, Mladen, Rozeman, Phillip, Espinoza, Andrey, Pereira, Edward, Spriggs, Douglas, Nahhas, Ahed, Sharma, Mukesh, Bayron, Carlos, Gilmore, Richard, Ball, Eric, Mrabti, Asmaa, Kralova, Katarina, Etienne, Alexis

“…After acute coronary syndrome, diabetes conveys an excess risk of ischaemic cardiovascular events. A reduction in mean LDL cholesterol to 1·4–1·8 mmol/L with…”
Get full text

Outcomes of Patients Supported with ECMO as a Bridge to Durable Mechanical Circulatory Support: An Analysis of the STS Intermacs Database by Loyaga-Rendon, R.Y., Boeve, T., Tallaj, J., Lee, S., Leacche, M., Koehl, D.A., Cantor, R.S., Lotun, K., Acharya, D.

“…To analyze the clinical characteristics and outcomes of patients who were bridged with ECMO to durable mechanical circulatory support (dMCS). Adult patients…”
Get full text

Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes by Roe, Matthew T., Li, Qian H., Bhatt, Deepak L., Bittner, Vera A., Diaz, Rafael, Goodman, Shaun G., Harrington, Robert A., Jukema, J. Wouter, Lopez-Jaramillo, Patricio, Lopes, Renato D., Louie, Michael J., Moriarty, Patrick M., Szarek, Michael, Vogel, Robert, White, Harvey D., Zeiher, Andreas M., Baccara-Dinet, Marie T., Steg, Ph Gabriel, Schwartz, Gregory G.

“…BACKGROUNDThe 2018 US cholesterol management guidelines recommend additional lipid-lowering therapies for secondary prevention in patients with low-density…”
Get full text

Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial by Szarek, Michael, Steg, Ph. Gabriel, DiCenso, Dina, Bhatt, Deepak L., Bittner, Vera A., Budaj, Andrzej, Diaz, Rafael, Goodman, Shaun G., Gotcheva, Nina, Jukema, J. Wouter, Pordy, Robert, Roe, Matthew T., Sourdille, Timothée, White, Harvey D., Xavier, Denis, Zeiher, Andreas M., Schwartz, Gregory G.

“…BACKGROUNDIn ODYSSEY OUTCOMES (Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab), alirocumab was…”
Get full text

VEGF and bFGF stimulate myocardial vascularization in embryonic chick by Tomanek, R J, Lotun, K, Clark, E B, Suvarna, P R, Hu, N

“…We tested the hypothesis that early vascularization of the embryonic heart is enhanced after bolus injections of vascular, endothelial growth factor (VEGF) and…”
Get full text

Practice-based randomized controlled-comparison clinical trial of chiropractic adjustments and brief massage treatment at sites of subluxation in subjects with essential hypertension: Pilot study by Plaugher, Gregory, Long, Cynthia R., Alcantara, Joel, Silveus, Alyssa D., Wood, Herbert, Lotun, Kapildeo, Menke, J.Michael, Meeker, William C., Rowe, Stephen H.

“…Objective: To determine the feasibility of conducting a randomized clinical trial in the private practice setting examining short- and long-term effects of…”
Get full text